Scientists modify fentanyl, aim to make it less deadly, less addictive | Washington University School of Medicine in St. Louis
Visit the news center The aim is to reduce the dangerous side effects of the powerful opioid painkiller
Visit the news center The aim is to reduce the dangerous side effects of the powerful opioid painkiller
Former Cerebral CEO Kyle Robertson has just informed the company that he may be preparing for a lawsuit. Robertson was kicked out in May amid concerns over Cerebral’s prescribing practices. The letter demands that Robertson have access to internal Cerebral files. Kyle Robertson, the former CEO of Cerebral, sent a letter to the company on …